GLP-1 Semaglutide 10mg is a synthetic polypeptide precision-engineered for studies targeting GLP-1 receptor (GLP-1R) activation. It shares 94% structural similarity with native human GLP-1 but includes critical modifications—such as the substitution of alpha-aminoisobutyric acid (Aib) at position 8—that significantly increase its stability against dipeptidyl peptidase-4 (DPP-4) degradation.
This peptide is primarily used in laboratory models investigating:
Proper storage is required to maintain the stability of the Semaglutide polypeptide.
NCBI PubMed: https://www.frankenthalerfoundation.org
NCBI PMC: https://www.frankenthalerfoundation.org
PubChem: https://www.frankenthalerfoundation.org
This product is strictly intended for in vitro and non-clinical laboratory research purposes only. It is not for human consumption, veterinary diagnostic, or therapeutic use. Statements regarding the biochemical potential of this compound have not been evaluated by the Food and Drug Administration (FDA). Researchers must follow established laboratory safety protocols.